Taro Pharmaceuticals USA, Inc

Taro is a leading manufacturer and supplier of topical dermatologic and specialty products, with millions of Americans relying on the company’s brand, generic, and OTC private-label products every year. With a deep-rooted network of key opinion leaders, Taro focuses on consistent quality, supply, and business continuity across all trade channels.

As an industry leader in generic manufacturing and distribution, Taro has stateof- the-art manufacturing facilities in Israel and Canada. Both sites have capabilities for research and development and advanced-product development. Taro uses several unique processing and supply chain procedures that result in excellent service rates. The company manufactures active pharmaceutical ingredient (API) and finished dosage forms for many key medications, allowing tight control of quality and consistency of supply. The vertical integration on API allows Taro to be cost competitive in the generic drug business and supports Taro’s commitment to provide high-quality and reasonably priced prescription drug products to consumers.

Taro continues to see strong improvements in its key metrics, including net sales and debt reduction. In addition, Taro has a significant cash position to provide a platform for growth, along with strong backing by Sun Pharmaceutical Industries, Ltd, a major shareholder of Taro with an international presence in the generic industry.

Taro’s US customer mix is well diversified among retail chains, drug wholesalers, managed care providers, government entities, and other classes of trade, resulting in a well-balanced market presence. Taro’s products rank #1 in market share for approximately 40% of its portfolio. Would you like to learn more about Taro’s high-quality, affordable products? Whether you are a physician, pharmacist, or patient, Taro is here for you.

For more information, visit http://www.taro.com.